Ospedale San Raffaele S.r.l. - PPDS

Milan 20132

2 studies enrolling now · 8 studies all time

What they study most

AML Arising From Myelodysplastic Syndrome (MDS), HIV-1 Infection, IgG4 Related Disease, Leukemia, Myeloid, Acute, Metastatic HER2-positive Breast Cancer, Metastatic or Unresectable Cutaneous Melanoma, Newly Diagnosed Acute Myeloid Leukemia (AML), Prader-Willi Syndrome, Systemic Sclerosis, Untreated AML

Studies at this site

• A Study of Pitolisant in Patients With Prader-Willi Syndrome — Recruiting now
• A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breast Cancer — Recruiting now
• Study of AG-120 (Ivosidenib) vs. Placebo in Combination With Azacitidine in Participants With Previously Untreated Acute Myeloid Leukemia With an IDH1 Mutation — Running, not enrolling
• A Phase 3 Study of Obexelimab in Patients With IgG4-Related Disease — Running, not enrolling
• A Clinical Study to Test Long Term Safety of GLPG1690 for Patients With Systemic Sclerosis — Stopped early
• Study to Evaluate the Safety and Efficacy of Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Abacavir/Dolutegravir/Lamivudine in Human Immunodeficiency Virus-1 (HIV-1) Infected, Antiretroviral Treatment-Naive Adults — Completed
• A Clinical Study to Test How Effective and Safe GLPG1690 is for Participants With Systemic Sclerosis — Completed
• Study Comparing the Efficacy of MEK162 Versus Dacarbazine in Unresectable or Metastatic NRAS Mutation-positive Melanoma — Completed